WEB Docquity Drives Demand for SIT Pharma's Duo Probiotics in Thailand, Achieving 31% Sales Growth in 6 Months
WEB Docquity's A2A Program and Local Distribution Network Fuel Success
Bangkok, Thailand, Feb. 13, 2024 /PRNewswire/ -- WEB Docquity, Southeast Asia's largest healthcare professional (HCP) community, has increased the reach of SIT Pharma's duo probiotics in Thailand to 2,000 HCPs, resulting in a 31% sales growth in just six months.
WEB Docquity's Awareness to Advocacy (A2A) Program and strong local distribution network played a pivotal role in the success of SIT Pharma's duo probiotics, which include SIT Probio 15B and SIT Probio Biotic 30B.
The A2A Program provided a platform for SIT Pharma to engage with HCPs through webinars, product updates, and scientific discussions. The strong local distribution network ensured that the probiotics were readily available to HCPs and patients.
"The partnership with WEB Docquity has been instrumental in expanding our reach to HCPs in Thailand and driving demand for our duo probiotics," said a representative from SIT Pharma.
"Our A2A Program and local distribution network have proven to be effective in increasing awareness and adoption of innovative healthcare solutions," said a spokesperson from WEB Docquity.
The success of SIT Pharma's duo probiotics in Thailand demonstrates WEB Docquity's commitment to empowering HCPs and providing patients with access to quality healthcare solutions.
Comments